martes, 16 de abril de 2019

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Daily Recap

In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead

By MATTHEW HERPER AND REBECCA ROBBINS


NEILSON BARNARD/GETTY IMAGES FOR THE NEW YORK TIMES
It is the company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

No hay comentarios: